Drugs / LAIV H5N2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01719783 | Sep 2012 → Jan 2013 | influenza | PATH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAIV H5N2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01719783 ↗ |
| Modality | Vaccine | “live attenuated influenza vaccine (LAIV)” PMID 26432909 ↗ Oct 2015 |
| Route | Intranasal | “Two doses of vaccine or placebo were administered intranasally to 30 and 10 subjects, respectively.” PMID 26296497 ↗ Aug 2015 |